Fluids are given when someone's body fluid volume falls. There are a number of things which may cause a drop in fluid volume. Vomiting and diarrhea are a classic example, which is why people are encouraged to drink fluids once they are sick, to stay their fluid volume stable. Another cause is blood loss, which causes problems both because people lose blood products, and since they experience a loss in fluid volume. Electrolyte levels within the blood also can become unstable as a results of rapid changes in fluid volume, during which case intravenous fluids are often used to restore the balance. Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the cardiovascular system. These fluids must be sterile to guard patients from injury, and there are variety of various types available to be used. Many companies manufacture packaged intravenous fluids, as well as products which may be mixed with sterile water to organize a solution for intravenous administration.
The global Intravenous (IV) solutions market was valued at USD 6.9 billion in 2015 and is projected to grow at a CAGR of 7.8% over the forecast period. The emergence of this market is attributed to the fast growing geriatric population and prevalence of malnutrition within the elderly and pediatric population. Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation. These fluids are sterile fluids which protects patients at the time of serious dehydration. There’s various type of IV solutions available to be used within the market. Many companies manufacture packaged intravenous fluids or products or compounds which may be mixed with sterile water to organize an answer for intravenous administration.
The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. This is attributed to the factors such as Growing acceptance of vitamin C intravenous for Colorectal Cancer and increasing prevalence of the chronic diseases. Europe is the second largest market which is growing at a CAGR of 8.12% from 2016-2022. Asia-Pacific region is the fastest growing market for IV Solutions, which is expected to grow at a CAGR of 8.34% during the forecast period from 2016 to 2022.
Few Indian major players are as under
Shree Krishna Keshav Laboratories Ltd.
Pharmazell (India) Pvt. Ltd.
Parenteral Surgicals Ltd.
Kokad Pharmaceutical Laboratories Ltd.
Ahlcon Parenterals (India) Ltd.
Abaris Healthcare Pvt. Ltd.
Axa Parenterals Ltd.
